Impact of Postremission Consolidation Chemotherapy on Outcome After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia in First Complete Remission

Yeshurun, Moshe; Labopin, Myriam; Blaise, Didier; Cornelissen, Jan; Sengeloev, Henrik; Vindelov, Lars; Kuball, Juergen; Chevallier, Patrice; Craddock, Charles; Socie, Gerard; Bilger, Karin; Schouten, Harry; Fegueux, Nathalie; GÖKER, HAKAN; Maertens, Johan; Bunjes, Donald; Arnold, Renate; Nagler, Arnon; Mohty, Mohamad

doi:10.1002/cncr.28498

Impact of Postremission Consolidation Chemotherapy on Outcome After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia in First Complete Remission

Yeshurun M., Labopin M., Blaise D., Cornelissen J. J., Sengeloev H., Vindelov L., ...Daha Fazla

CANCER, cilt.120, sa.6, ss.855-863, 2014 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 120 Sayı: 6
Basım Tarihi: 2014
Doi Numarası: 10.1002/cncr.28498
Dergi Adı: CANCER
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.855-863
Hacettepe Üniversitesi Adresli: Evet

Özet

BACKGROUNDThe objective of the current study was to investigate the role of postremission consolidation chemotherapy before reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (alloSCT) for patients with acute myeloid leukemia (AML) in first complete remission (CR1).